Home/Syndeio Biosciences/Derek Small

DS

Derek Small

Co-founder and Chief Executive Officer

Syndeio Biosciences

Therapeutic Areas

Neuropsychiatric Disorders Cognitive Disorders Major Depressive Disorder Alzheimer's Disease

Syndeio Biosciences Pipeline

Drug	Indication	Phase
Zelquistinel	Major Depressive Disorder (MDD)	Phase 2
Apimostinel	Major Depressive Disorder (Severe, Acute)	Phase 2a

Leadership Team at Syndeio Biosciences

Michael McCully

President and Chief Operating Officer

John Donello, Ph.D.

Chief Science Officer

Aaron Koenig, M.D.

Chief Medical Officer

Thomas C. Südhof, M.D.

Co-chair of Scientific Advisory Board

View full Syndeio Biosciences profile